Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal of Neuropathology and Experimental Neurology
|
November 1, 1975
An immunopathologic component in experimental togavirus encephalitis
D L Camenga, N Nathanson
The Journal of Infectious Diseases
|
December 1, 1974
Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors
D L Camenga, N Nathanson, G A Cole
The International Journal of Neuroscience
|
April 1, 1988
The placebo effect during a double blind trial of recombinant alpha 2 interferon in multiple sclerosis patients: immunological and clinical findings
R L Hirsch, K P Johnson, D L Camenga
Journal of Neuropathology and Experimental Neurology
|
January 1, 1977
Anticonvulsant prolongation of survival in adult murine lymphocytic choriomeningitis. I. Drug treatment and virologic studies
D L Camenga, D H Walker, F A Murphy
Journal of Neuropathology and Experimental Neurology
|
January 1, 1977
Anticonvulsant prolongation of survival in adult murine lymphocytic choriomeningitis. II. Ultrastructural observations of pathogenetic events
D H Walker, D L Camenga, S Whitfield, et al.
Archives of Neurology
|
January 1, 1981
Recurrent herpes zoster encephalitis. A complication of systemic lupus erythematosus
P P O'Donnell, T P Pula, M Sellman, et al.
Annals of the New York Academy of Sciences
|
June 6, 1994
Familial Creutzfeldt-Jakob disease
D L Camenga, L G Goldfarb, D Bierke-Nelson, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
August 30, 1989
[Herpes simplex 1 virus encephalitis. Early diagnosis with magnetic tomography (MT)]
J S Bakken, D L Camenga, M C Glazier, et al.
Annals of Neurology
|
April 1, 1990
Preliminary trial of 3,4-diaminopyridine in patients with multiple sclerosis
C T Bever, J Leslie, D L Camenga, et al.
Archives of Neurology
|
December 1, 1986
Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis
D L Camenga, K P Johnson, M Alter, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal of Neuropathology and Experimental Neurology
|
November 1, 1975
An immunopathologic component in experimental togavirus encephalitis
D L Camenga, N Nathanson
The Journal of Infectious Diseases
|
December 1, 1974
Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors
D L Camenga, N Nathanson, G A Cole
The International Journal of Neuroscience
|
April 1, 1988
The placebo effect during a double blind trial of recombinant alpha 2 interferon in multiple sclerosis patients: immunological and clinical findings
R L Hirsch, K P Johnson, D L Camenga
Journal of Neuropathology and Experimental Neurology
|
January 1, 1977
Anticonvulsant prolongation of survival in adult murine lymphocytic choriomeningitis. I. Drug treatment and virologic studies
D L Camenga, D H Walker, F A Murphy
Journal of Neuropathology and Experimental Neurology
|
January 1, 1977
Anticonvulsant prolongation of survival in adult murine lymphocytic choriomeningitis. II. Ultrastructural observations of pathogenetic events
D H Walker, D L Camenga, S Whitfield, et al.
Archives of Neurology
|
January 1, 1981
Recurrent herpes zoster encephalitis. A complication of systemic lupus erythematosus
P P O'Donnell, T P Pula, M Sellman, et al.
Annals of the New York Academy of Sciences
|
June 6, 1994
Familial Creutzfeldt-Jakob disease
D L Camenga, L G Goldfarb, D Bierke-Nelson, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
August 30, 1989
[Herpes simplex 1 virus encephalitis. Early diagnosis with magnetic tomography (MT)]
J S Bakken, D L Camenga, M C Glazier, et al.
Annals of Neurology
|
April 1, 1990
Preliminary trial of 3,4-diaminopyridine in patients with multiple sclerosis
C T Bever, J Leslie, D L Camenga, et al.
Archives of Neurology
|
December 1, 1986
Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis
D L Camenga, K P Johnson, M Alter, et al.
Page
of 1